North American stock-car racing series Nascar has entered into an agreement that makes Janssen Pharmaceuticals its official cardiovascular partner.
Janssen Pharmaceuticals is the pharmaceutical arm of healthcare products company Johnson & Johnson and the partnership will focus on raising awareness among Nascar fans who are at risk of, or are living with, blood clots.
The company’s Xarelto medicine is used to treat and prevent blood clots. It was the medicine of choice for Nascar driver Brian Vickers when he overcame a second bout of the condition last year before returning to competition.
Terms of the deal were not disclosed, but under the agreement Vickers on Sunday competed at the Auto Club Speedway in a custom TreatMyClot.com Aaron’s Dream Machine Toyota Camry co-sponsored by Janssen. Additionally, TreatMyClot.com served as title sponsor of the weekend’s Nationwide Series race at Auto Club Speedway in Fontana, California.
“We are encouraged to see Janssen Pharmaceuticals’ level of dedication to helping fans affected by blood clots,” Jim O’Connell, Nascar chief sales officer, said. “We welcome them to the Nascar family, not only as an official partner but also as a race entitlement and team sponsor.”